Run by Eurasanté.
Eurasanté's Bio-Acceleration programme takes health, biotech and medtech companies in Lille on a rolling, in-person basis, and its own page describes it as 24 months to boost the company — though a second Eurasanté page lists 18 months for the same programme. It awards no cheque itself, instead supporting non-dilutive funding applications and Series A preparation, and states it takes no equity stake in any project on its programmes.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Compare all 5 Eurasanté programmes.
Last verified 2026-09-06.